STRATA Skin Sciences Inc (SSKN) - Total Liabilities

Latest as of December 2025: $27.61 Million USD

Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) has total liabilities worth $27.61 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

STRATA Skin Sciences Inc - Total Liabilities Trend (2002–2025)

This chart illustrates how STRATA Skin Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. See STRATA Skin Sciences Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

STRATA Skin Sciences Inc Competitors by Total Liabilities

The table below lists competitors of STRATA Skin Sciences Inc ranked by their total liabilities.

Company Country Total Liabilities
NeutriSci International Inc
V:NU
Canada CA$1.04 Million
GenixPharmaceucticals Corporation
V:GENX
Canada CA$1.51 Million
Nicolas Miguet et Associes SA
PA:MLNMA
France €1.05 Million
Greencastle Resources Ltd.
V:VGN
Canada CA$73.75K
Ristia Bintang Mahkotasejati
JK:RBMS
Indonesia Rp291.12 Billion
CENTAURUS ENERGY INC.
F:72M0
Germany €5.59 Million
Michelmersh Brick Holdings Plc
LSE:MBH
UK GBX36.10 Million
Geiger Counter Limited
LSE:GCL
UK GBX11.26 Million

Liability Composition Analysis (2002–2025)

This chart breaks down STRATA Skin Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see STRATA Skin Sciences Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.58 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 9.50 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.90 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how STRATA Skin Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for STRATA Skin Sciences Inc (2002–2025)

The table below shows the annual total liabilities of STRATA Skin Sciences Inc from 2002 to 2025.

Year Total Liabilities Change
2025-12-31 $27.61 Million -11.45%
2024-12-31 $31.18 Million +6.33%
2023-12-31 $29.33 Million -3.66%
2022-12-31 $30.44 Million +43.73%
2021-12-31 $21.18 Million +1.40%
2020-12-31 $20.89 Million +11.75%
2019-12-31 $18.69 Million +14.95%
2018-12-31 $16.26 Million -0.78%
2017-12-31 $16.39 Million -42.45%
2016-12-31 $28.47 Million -19.30%
2015-12-31 $35.28 Million +352.72%
2014-12-31 $7.79 Million +33.55%
2013-12-31 $5.84 Million +77.14%
2012-12-31 $3.29 Million +107.74%
2011-12-31 $1.59 Million -11.42%
2010-12-31 $1.79 Million -1.15%
2009-12-31 $1.81 Million +18.36%
2008-12-31 $1.53 Million +14.50%
2007-12-31 $1.34 Million +15.03%
2006-12-31 $1.16 Million +26.78%
2005-12-31 $916.34K -91.39%
2004-12-31 $10.65 Million +1537.88%
2003-12-31 $650.00K -87.00%
2002-12-31 $5.00 Million --

About STRATA Skin Sciences Inc

NASDAQ:SSKN USA Medical Devices
Market Cap
$877.34K
Market Cap Rank
#30586 Global
#6122 in USA
Share Price
$0.15
Change (1 day)
+0.00%
52-Week Range
$0.11 - $2.83
All Time High
$60.50
About

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more